Astria Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Astria Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Astria Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Astria Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $339k | 64k | 5.34 |
| 2024-12-31 | $567k | 64k | 8.94 |
| 2024-09-30 | $613k | 56k | 11.01 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas